Gyre Therapeutics Inc Revenue per Employee (GYRE), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Gyre Therapeutics Inc   (NASDAQ: GYRE)
 

Gyre Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 7.75% in the third quarter 2026, year on year to cumulative value of $122 million, Gyre Therapeutics Inc 's revenue per employee grew on a trailing twelve months basis to $ 197,011, this is below the company average.
Within the Healthcare sector Employees of 396 other companies have achieved higher revenue per employee. While Gyre Therapeutics Inc 's total ranking has deteriorated compared to the previous quarter from 2781 to 3001. Gyre Therapeutics Inc has 618 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GYRE Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change 7.75 % 8.72 % 2.09 % 33.45 % 19.92 %
Sales per Employee (TTM) $ 197,011 193,176 189,400 188,654 173,568
GYRE's Total Ranking # 3001 # 2781 # 150 # 140 #
Seq. Revenue Change 13.16 % 29.25 % -39.46 % 21.7 % 14.17 %

GYRE Company Profile >> Back to GYRE Efficiency Comparisons >> Compare GYRE Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 149
Healthcare Sector # 397
Overall Market # 3001

Revenue per Employee Statistics
High Average Low
$ 193,176 $ 57,755 $ 353
(Jun 30 2026)   (Sep 30 2016)



Financial Statements
Gyre Therapeutics Inc 's Revenue MRQ $ 33 Millions Visit GYRE's Income Statement
Gyre Therapeutics Inc 's Revenues TTM $ 122 Millions Visit GYRE's aggregate revenue growth
What are GYRE's Sales? Visit GYRE's Sales by Segment




Other Ratios
Gyre Therapeutics Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
GYRE's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for GYRE's Competitors
Revenue per Employee for GYRE's Suppliers
Revenue per Employee for GYRE's Customers

You may also want to know
GYRE's Sales Growth Rates GYRE's Pe Price to earnings ratio GYRE's Receivables Turnover Ratio GYRE's Stock Quote
GYRE's Net Income Growth Rates GYRE's Ps Price to Sales ratio GYRE's Sales per Employee GYRE's Asset Turnover Ratio
GYRE's Net Margin GYRE's Pb Price to Book ratio GYRE's Financial Strength Ratios GYRE's Dividend Payout Ratio
Date modified: 2026-11-07T13:17:42+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Neogen Corporation  335,402.12 $ 884.120  Million 2,636 
Ceribell Inc   333,954.13 $ 109.203  Million 327 
Aquestive Therapeutics Inc   332,224.49 $ 48.837  Million 147 
Penumbra Inc  331,985.96 $ 1,560.334  Million 4,700 
Tactile Systems Technology Inc   328,891.34 $ 357.176  Million 1,086 
Bruker Corporation  316,869.64 $ 3,512.500  Million 11,085 
Biodesix Inc   315,005.99 $ 105.212  Million 334 
West Pharmaceutical Services Inc   314,546.30 $ 3,397.100  Million 10,800 
Baxter International Inc   314,240.00 $ 11,784.000  Million 37,500 
Beta Bionics Inc   304,521.43 $ 127.899  Million 420 
Pulmonx Corporation  301,270.27 $ 89.176  Million 296 
Pediatrix Medical Group Inc   298,874.75 $ 1,959.124  Million 6,555 
Bicycle Therapeutics Plc  290,027.78 $ 83.528  Million 288 
Adapthealth Corp   289,178.26 $ 3,152.043  Million 10,900 
Beam Therapeutics Inc   286,974.56 $ 146.644  Million 511 
Wave Life Sciences Ltd   275,381.70 $ 87.296  Million 317 
Rxsight Inc   264,832.97 $ 122.088  Million 461 
Clearpoint Neuro Inc   264,494.19 $ 45.493  Million 172 
Cryoport inc   260,757.45 $ 192.439  Million 738 
Dentsply Sirona Inc   255,357.14 $ 3,575.000  Million 14,000 
Ideaya Biosciences Inc   251,965.52 $ 36.535  Million 145 
Zai Lab Limited  247,604.82 $ 441.727  Million 1,784 
Hca Healthcare Inc   245,940.63 $ 78,701.000  Million 320,000 
Fulgent Genetics Inc   245,441.22 $ 329.873  Million 1,344 
Tenet Healthcare Corp  223,777.78 $ 22,154.000  Million 99,000 
Merit Medical Systems Inc  214,964.80 $ 1,612.236  Million 7,500 
Standard Biotools Inc   214,889.46 $ 83.592  Million 389 
Labcorp Holdings Inc   208,492.86 $ 14,594.500  Million 70,000 
Quest Diagnostics Inc  207,736.84 $ 11,841.000  Million 57,000 
Pacific Health Care Organization Inc  205,413.39 $ 6.368  Million 31 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.